- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statements (Forms S-8 No. 333-128805, 333-163006, 333-177819, 333-207903 and 333-213079) pertaining to the 2001 Stock Incentive Plan, the 2005 Stock Incentive Plan, and the Employee Stock Purchase Plan of Genomic Health, Inc., respectively, and |
(2) | Registration Statements (Form S-3 No. 333-141946, 333-167868, 333-188571, 333-213074, and 333-213076) of Genomic Health, Inc.; |
of our reports dated March 14, 2018, with respect to the consolidated financial statements and schedule of Genomic Health, Inc., and the effectiveness of internal control over financial reporting of Genomic Health, Inc. included in this Annual Report (Form 10-K) of Genomic Health, Inc. for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Redwood City, California
March 14, 2018